William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
El Pollo Loco (LOCO) CEO Announces Immediate Resignation, William Blair Reiterates Market Perform
-
UPDATE: William Blair Starts Toast Inc. (TOST) at Outperform
-
9 Things to Know About the Upcoming ~$1.9 Billion Enfusion (ENFN) IPO
-
MiNK Therapeutics (INKT) IPO Opens About Flat
-
Clearlake Capital Completes Acquisition of Cornerstone OnDemand
-
Clearlake Capital Completes Acquisition of Cornerstone OnDemand
-
MiNK Therapeutics, Inc. (INKT) Prices 3.33M Share IPO $12/sh
-
MiNK Therapeutics, Inc. Announces Pricing of Initial Public Offering
-
MiNK Therapeutics, Inc. Announces Pricing of Initial Public Offering
-
GitLab (GTLB) IPO Opens 22% Higher, Valuing Stock at $13.5 Billion
-
Global Decision Analytics Company Copperleaf Completes Initial Public Offering
-
GitLab Inc (GTLB) Prices 10.4M Share IPO at $77, Above the Expected $66-$69 Range
-
GitLab Announces Pricing of Initial Public Offering
-
GitLab Announces Pricing of Initial Public Offering
-
UserTesting Files Registration Statement for Proposed Initial Public Offering
-
7 Things to Know About the Upcoming $1.1 Billion IPO of Vita Coco Company (COCO) Stock
-
8 Things to Know About Hot Dog Chain Portillo's (PTLO) IPO
-
William Blair Downgrades Neuronetics (STIM) to Market Perform, Following Earnings
-
Revelstoke Completes Exit of Carrus
-
Paradigm Announces Strategic Growth Investment From Francisco Partners
-
ASG’s Paradigm Announces Strategic Growth Investment from Francisco Partners
-
Beacon Roofing Supply (BECN) Checks Show Pricing Upside That Should Offset Negative Volume Growth - William Blair
-
Vroom (VRM) Acquisition is Accretive Day 1 but William Blair Holding Off on Raising Estaimtes
-
Revance Therapeutics (RVNC) Defended at William Blair Following FDA Form 483
-
Fintech firm Halo raises money from Owl Capital, Mubadala
-
The Vita Coco Company, Inc. Announces Launch of Initial Public Offering
-
Halo Investing Announces over US$ 100m in Funding to Expand Access to Protective Investments
-
Pre-Open Stock Movers 10/12: (RRD) (TARA) (QTRX) Higher; (CVAC) (RLAY) (TREX) Lower (more...)
-
Short Seller Target Ginkgo Bioworks (DNA) Receives New 'Buy' Rating
-
Enfusion Announces Launch of Initial Public Offering
-
William Blair Downgrades Citrix Systems (CTXS) to Market Perform
-
UPDATE: William Blair Starts Ginkgo Bioworks Holdings Inc (DNA) at Outperform
-
10 Things to Know About the Upcoming Nearly $10 Billion GitLab (GTLB) IPO
-
William Blair Downgrades Adamas Pharmaceuticals (ADMS) to Market Perform, Following Acquisition
-
Greenidge Generation Announces Upsizing and Pricing of 8.50% Senior Unsecured Notes Due 2026
-
Nuvei Announces Closing of US $ 424,833,000 Initial Public Offering in the United States
-
IPO for Pyxis Oncology (PYXS) Upsized IPO Opens 19% Higher, Valuing Co. at ~$580M
-
Highlander Partners Announces the Acquisition of RMS Beauty, the Pioneer Brand of the Clean Beauty Movement
-
Pyxis Oncology, Inc. (PYXS) Prices Upsized 10.5M Share IPO at $16/sh
-
Pyxis Announces Pricing of Upsized Initial Public Offering
-
RBC Bearings Incorporated Completes Debt and Equity Offerings for Financing of Pending Dodge Acquisition
-
Permira Agrees to Make Strategic Investment in Motus
-
Science 37 Closes Business Combination with LifeSci Acquisition II Corp. (LSAQ) and Will Begin Trading on Nasdaq as SNCE
-
Science 37, the Operating System for Agile Clinical Trials, Closes Business Combination with LifeSci Acquisition II Corp. and Will Begin Trading on Nasdaq as SNCE
-
Science 37, the Operating System for Agile Clinical Trials, Closes Business Combination with LifeSci Acquisition II Corp. and Will Begin Trading on Nasdaq as SNCE
-
Global Decision Analytics Company Copperleaf Announces Pricing and Upsizing of Initial Public Offering to $140.1 Million
-
Form D WILLIAM BLAIR MB INVESTM
-
9 Things to Know About the Pyxis Oncology (PYXS) IPO, Spinout of University of Chicago
-
William Blair Sees Palantir Technologies Inc. (PLTR) Post Market Jump as Overreaction Considering the White House Cut its Budget
-
Appian Corp. (APPN) Margin Targets Increase at its First Ever Analyst Day - William Blair

